NantHealth (NH) Given a $5.00 Price Target at Jefferies Group

Jefferies Group set a $5.00 price target on NantHealth (NASDAQ:NH) in a report published on Wednesday. The brokerage currently has a buy rating on the stock.

Other research analysts also recently issued reports about the company. BidaskClub upgraded NantHealth from a strong sell rating to a sell rating in a research note on Tuesday, January 9th. Zacks Investment Research upgraded NantHealth from a hold rating to a buy rating and set a $4.25 target price on the stock in a research note on Thursday, January 11th. Finally, Cowen reiterated a buy rating and issued a $4.50 target price on shares of NantHealth in a research note on Tuesday, March 20th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $7.46.

How to Become a New Pot Stock Millionaire

NH stock opened at $3.12 on Wednesday. NantHealth has a 12-month low of $2.60 and a 12-month high of $5.70. The company has a market capitalization of $344.20, a P/E ratio of -2.09 and a beta of 0.64. The company has a debt-to-equity ratio of 1.01, a quick ratio of 2.36 and a current ratio of 2.28.

In related news, COO Ronald Allen Louks sold 7,095 shares of NantHealth stock in a transaction that occurred on Tuesday, March 6th. The stock was sold at an average price of $3.56, for a total value of $25,258.20. Following the sale, the chief operating officer now directly owns 89,690 shares in the company, valued at $319,296.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Over the last 90 days, insiders sold 19,745 shares of company stock worth $66,549. Company insiders own 58.00% of the company’s stock.

Institutional investors have recently bought and sold shares of the stock. Teachers Advisors LLC boosted its stake in shares of NantHealth by 351.8% in the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock valued at $134,000 after buying an additional 24,588 shares in the last quarter. California State Teachers Retirement System boosted its stake in shares of NantHealth by 132.4% in the second quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock valued at $134,000 after buying an additional 18,000 shares in the last quarter. Citadel Advisors LLC purchased a new stake in shares of NantHealth in the fourth quarter valued at approximately $103,000. Schwab Charles Investment Management Inc. purchased a new stake in shares of NantHealth in the third quarter valued at approximately $180,000. Finally, Deutsche Bank AG boosted its stake in shares of NantHealth by 117.4% in the fourth quarter. Deutsche Bank AG now owns 45,610 shares of the company’s stock valued at $137,000 after buying an additional 24,635 shares in the last quarter. Hedge funds and other institutional investors own 6.27% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “NantHealth (NH) Given a $5.00 Price Target at Jefferies Group” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3298288/nanthealth-nh-given-a-5-00-price-target-at-jefferies-group.html.

NantHealth Company Profile

NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.

Analyst Recommendations for NantHealth (NASDAQ:NH)

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

WEC Energy Group  Receives Media Impact Rating of 0.31
WEC Energy Group Receives Media Impact Rating of 0.31
Welltower  Receiving Favorable Press Coverage, Report Shows
Welltower Receiving Favorable Press Coverage, Report Shows
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact IHS Markit  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact IHS Markit Stock Price
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Coca-Cola European Partners  Stock Price
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Coca-Cola European Partners Stock Price
Karmacoin Price Up 16% Over Last 7 Days
Karmacoin Price Up 16% Over Last 7 Days
Compcoin Hits Market Capitalization of $0.00
Compcoin Hits Market Capitalization of $0.00


© 2006-2018 Ticker Report. Google+.